CHEMOMAB THERAPEUTICS LTD (CMMB)

US16385C1045 - ADR

0.77  +0.02 (+2.8%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to CMMB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.14. This target is 827.27% above the current price.
CMMB was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CMMB.
In the previous month the buy percentage consensus was at a similar level.
CMMB was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.777.077.147.147.35 - 818.18% 827.27% 827.27% 854.55%
Up and Down Grades
Date Firm Action Rating
2024-03-08 Oppenheimer Maintains Perform -> Perform
2023-12-19 Roth MKM Reiterate Buy
2023-10-06 Roth MKM Initiate Buy
2023-06-07 Oppenheimer Downgrade Outperform -> Perform
2023-04-18 Oppenheimer Maintains Outperform
2022-03-10 Oppenheimer Maintains Outperform
2021-12-07 Aegis Capital Initiate Buy
2021-05-26 Cantor Fitzgerald Initiate Overweight
2021-05-07 Oppenheimer Initiate Outperform